Hims & Hers Health, Inc. (NYSE: HIMS), a leading health and wellness platform, today announced the expansion of its weight loss services with the introduction of a Compounded Semaglutide Pill, offering the same active ingredient as Wegovy® in a needle-free form. The new pill joins Hims & Hers’ growing suite of personalized weight loss solutions designed to meet the unique needs of each customer.
The move aims to make weight loss treatments more accessible and tailored. Leveraging nearly a decade of infrastructure investment, Hims & Hers is offering eligible customers an introductory plan starting at $49 for the first month, making personalized care more affordable than ever.*
The Compounded Semaglutide Pill is specially formulated to protect the active ingredient during digestion and enhance absorption. This delivery method allows providers to customize treatments for patients who prefer to avoid injections or are seeking to minimize side effects.
“We have spent years building the infrastructure to put the power of choice back into the hands of individuals,” said Andrew Dudum, co-founder and CEO of Hims & Hers. “This expansion ensures providers can offer a variety of safe, effective options that fit each patient’s lifestyle. More choice on the platform is always better for customers.”
Dr. Craig Primack, MD, Head of Weight Loss at Hims & Hers, emphasized the clinical benefits: “Whether a patient requires a specific dosage adjustment or prefers a pill over an injection, our platform supports a higher level of personalization. This allows customers to receive weight loss treatment plans tailored to their individual needs, promoting benefits such as improved metabolism, better sleep, and increased energy.”
Hims & Hers’ approach emphasizes choice for both providers and patients, with treatment plans guided by licensed clinicians. The platform now offers an extensive range of weight loss options, including branded, generic, and compounded medications, alongside 24/7 care team support and educational resources covering nutrition, mental health, and physical wellness.
In 2025, Hims & Hers doubled its facility footprint to over one million square feet, integrating advanced pharmacy, lab testing, and R&D capabilities. This infrastructure allows clinicians to offer individualized care at a scale and price point previously unavailable.
All compounded treatments adhere to federal and state regulations, with active pharmaceutical ingredients sourced exclusively from FDA-registered facilities to ensure quality and safety.
About Hims & Hers Health, Inc.
Hims & Hers is a leading health and wellness platform dedicated to helping people feel their best through personalized care. The company addresses a broad spectrum of health challenges and provides tailored solutions to promote overall well-being.
